Physician profile
Samuel Posey
NPI 1003215948
$3,347.43
in general payments reported to CMS, 2019-2025
11 companies · $475 in 2025
The $475 reported for 2025 was more than what 90% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $13.91 · 2022: $46.87 · 2023: $204 · 2024: $2,496 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,590 · Food and Beverage: $996 · Education: $589.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,589.94 |
| Food and Beverage | $996.32 |
| Education | $588.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $1,866.32 | 2024 | |
| Colgate Oral Pharmaceuticals, INC. | $388.95 | 2025 | |
| Zest Holdings, LLC | $250.65 | 2024-2025 | |
| Dentsply Sirona INC | $237.53 | 2022-2023 | Implant Dentistry, Waveone Gold Conform Fit, Consumable Dentistry |
| Straumann USA LLC | $236.79 | 2024 | |
| Kulzer, LLC | $199.03 | 2024 | |
| Biohorizons Implant Systems INC. | $90.64 | 2019 | |
| Philips North America LLC | $27.49 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $20.80 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $18.71 | 2025 | Arestin |
| Align Technology, INC. | $10.52 | 2024 | Invisalign |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Posey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.